Find news about people
Find news about organizations
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions


Change Feed
Investments in Pharmaceuticals
... Regen BioPharma, Inc. (OTC: RGBP), Celldex Therapeutics, Inc. (NASDAQ: CLDX), Onconova Therapeutics, Inc. (NASDAQ: ONTX), aTyr Pharma, Inc. (NASDAQ: LIFE), OncoSec Medical Incorporated (NASDAQ: ONCS) ...
... Dan Van Plew had two communities on his radar before Regeneron Pharmaceuticals picked a site for an $800 million expansion - Limerick, Ireland, ...
... financing was led by existing investor OrbiMed, with participation from new investors Celgene Corporation and Alexandria Venture Investments. Silverback's proprietary ImmunoTAC technology and integrated R&D ...
... MALVERN, Pa., Sept. 19, 2018 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc., a clinical-stage biotechnology company focused on the development of drugs targeting ...
... Immune-Onc Therapeutics, Inc. ("Immune-Onc"), a privately held cancer immunotherapy company dedicated to the discovery ...
... medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, and NovellusDx, Ltd., a leader in functional genomics, today announced the signing of a ...
... investor, Novo Nordisk, has also participated in Series B Corporate strategic partner, Zealand Pharm, previously committed $5m to Series B in December 2017 BOSTON, Sept. ...
... Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the "Company" or "Organigram"), a leading licensed producer of medical marijuana, ...
Subscribe now for full coverage on Investments in Pharmaceuticals
Start My Free Trial